Inora Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.75 M
as on 11-07-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 11-07-2024
- Satisfied Charges ₹ 0.60 M
as on 11-07-2024
- Revenue -14.38%
(FY 2022)
- Profit -14.46%
(FY 2022)
- Ebitda 12.73%
(FY 2022)
- Net Worth 34.38%
(FY 2022)
- Total Assets -19.72%
(FY 2022)
About Inora Biotech
The Corporate was formerly known as Umt Consultancy Services Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹6.00 M. The company has closed loans amounting to ₹0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Vrunda Panhalkar, Nutan Bhajekar, and Manjushree Tadwalkar serve as directors at the Company.
- CIN/LLPIN
U74995PN2000PTC015396
- Company No.
015396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Inora Biotech Private Limited offer?
Inora Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Bio Fertilizers, Insecticides, Biopesticides, Biofungicides, Trichoderma Viride, Organic Fertilizers and Manure, Humic Acid Powder and Liquid, Fertilizer, Micronutrient Fertilizers.
Who are the key members and board of directors at Inora Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vrunda Panhalkar  | Director | 12-Jul-2012 | Current |
| Nutan Bhajekar | Director | 29-Jan-2009 | Current |
| Manjushree Tadwalkar | Director | 08-Nov-2006 | Current |
Financial Performance of Inora Biotech.
Inora Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.38% decrease. The company also saw a substantial fall in profitability, with a 14.46% decrease in profit. The company's net worth Soared by an impressive increase of 34.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inora Biotech?
In 2021, Inora Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 May 2016 | ₹6.00 M | Open |
Others Creation Date: 29 Sep 2018 | ₹0.60 M | Satisfied |
How Many Employees Work at Inora Biotech?
Inora Biotech has a workforce of 26 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inora Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inora Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
